• Je něco špatně v tomto záznamu ?

Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology

E. Ertekin, IM. van Hagen, AM. Salam, TP. Ruys, MR. Johnson, J. Popelova, WA. Parsonage, Z. Ashour, A. Shotan, JM. Oliver, GR. Veldtman, R. Hall, JW. Roos-Hesselink,

. 2016 ; 220 (-) : 131-6. [pub] 20160623

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031614

OBJECTIVES: To describe the incidence, onset, predictors and outcome of ventricular tachyarrhythmia (VTA) in pregnant women with heart disease. BACKGROUND: VTA during pregnancy will cause maternal morbidity and even mortality and will have impact on fetal outcome. Insufficient data exist on the incidence and outcome of VTA in pregnancy. METHODS AND RESULTS: From January 2007 up to October 2013, 99 hospitals in 39 countries enrolled 2966 pregnancies in women with structural heart disease. Forty-two women (1.4%) developed clinically relevant VTA during pregnancy, which occurred mainly in the third trimester (48%). NYHA class >1 before pregnancy was an independent predictor for VTA. Heart failure during pregnancy was more common in women with VTA than in women without VTA (24% vs. 12%, p=0.03) and maternal mortality was respectively 2.4% and 0.3% (p=0.15). More women with VTA delivered by Cesarean section than women without VTA (68% vs. 47%, p=0.01). Neonatal death, preterm birth (<37weeks), low birthweight (<2500g) and Apgar score <7 occurred more often in women with VTA (4.8% vs. 0.3%, p=0.01; 36% vs. 16%, p=0.001; 33% vs. 15%, p=0.001 and 25% vs. 7.3%, p=0.001, respectively). CONCLUSIONS: VTA occurred in 1.4% of pregnant women with cardiovascular disease, mainly in the third trimester, and was associated with heart failure during pregnancy. NYHA class before pregnancy was predictive. VTA during pregnancy had clear impact on fetal outcome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031614
003      
CZ-PrNML
005      
20171026115031.0
007      
ta
008      
171025s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijcard.2016.06.061 $2 doi
035    __
$a (PubMed)27376569
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ertekin, Ebru $u Erasmus University Medical Center, Rotterdam, The Netherlands.
245    10
$a Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology / $c E. Ertekin, IM. van Hagen, AM. Salam, TP. Ruys, MR. Johnson, J. Popelova, WA. Parsonage, Z. Ashour, A. Shotan, JM. Oliver, GR. Veldtman, R. Hall, JW. Roos-Hesselink,
520    9_
$a OBJECTIVES: To describe the incidence, onset, predictors and outcome of ventricular tachyarrhythmia (VTA) in pregnant women with heart disease. BACKGROUND: VTA during pregnancy will cause maternal morbidity and even mortality and will have impact on fetal outcome. Insufficient data exist on the incidence and outcome of VTA in pregnancy. METHODS AND RESULTS: From January 2007 up to October 2013, 99 hospitals in 39 countries enrolled 2966 pregnancies in women with structural heart disease. Forty-two women (1.4%) developed clinically relevant VTA during pregnancy, which occurred mainly in the third trimester (48%). NYHA class >1 before pregnancy was an independent predictor for VTA. Heart failure during pregnancy was more common in women with VTA than in women without VTA (24% vs. 12%, p=0.03) and maternal mortality was respectively 2.4% and 0.3% (p=0.15). More women with VTA delivered by Cesarean section than women without VTA (68% vs. 47%, p=0.01). Neonatal death, preterm birth (<37weeks), low birthweight (<2500g) and Apgar score <7 occurred more often in women with VTA (4.8% vs. 0.3%, p=0.01; 36% vs. 16%, p=0.001; 33% vs. 15%, p=0.001 and 25% vs. 7.3%, p=0.001, respectively). CONCLUSIONS: VTA occurred in 1.4% of pregnant women with cardiovascular disease, mainly in the third trimester, and was associated with heart failure during pregnancy. NYHA class before pregnancy was predictive. VTA during pregnancy had clear impact on fetal outcome.
650    _2
$a dospělí $7 D000328
650    _2
$a císařský řez $x statistika a číselné údaje $7 D002585
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    12
$a srdeční selhání $x komplikace $x diagnóza $x epidemiologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a těhotenství $7 D011247
650    12
$a kardiovaskulární komplikace v těhotenství $x diagnóza $x mortalita $7 D011249
650    _2
$a výsledek těhotenství $x epidemiologie $7 D011256
650    _2
$a třetí trimestr těhotenství $7 D011263
650    _2
$a předčasný porod $x epidemiologie $x etiologie $7 D047928
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    12
$a komorová tachykardie $x diagnóza $x etiologie $x mortalita $7 D017180
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a van Hagen, Iris M $u Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Salam, Amar M $u Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
700    1_
$a Ruys, Titia P E $u Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Johnson, Mark R $u Imperial College School of Medicine, Chelsea and Westminster Hospital, London, United Kingdom.
700    1_
$a Popelova, Jana $u Hospital Na Homolce & Pediatric Heart Center University Hospital Motol, Prague, Czech Republic.
700    1_
$a Parsonage, William A $u Royal Brisbane & Women's Hospital, Herston, Australia.
700    1_
$a Ashour, Zeinab $u Cairo University, Cairo, Egypt. $7 gn_A_00009314
700    1_
$a Shotan, Avraham $u Hillel Yaffe Medical Center, Hadera, Israel.
700    1_
$a Oliver, José M $u Adult Congenital Heart Disease Unit, La Paz University Hospital, Madrid, Spain.
700    1_
$a Veldtman, Gruschen R $u Adolescent and Adult Congenital Heart Program, Cincinnati Children's Hospital, Cincinnati,United States.
700    1_
$a Hall, Roger $u Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
700    1_
$a Roos-Hesselink, Jolien W $u Erasmus University Medical Center, Rotterdam, The Netherlands; Fellow of the European Society of Cardiology, Sophia Antipolis Cedex, France. Electronic address: j.roos@erasmusmc.nl.
773    0_
$w MED00002299 $t International journal of cardiology $x 1874-1754 $g Roč. 220, č. - (2016), s. 131-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27376569 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171026115114 $b ABA008
999    __
$a ok $b bmc $g 1255207 $s 992641
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 220 $c - $d 131-6 $e 20160623 $i 1874-1754 $m International journal of cardiology $n Int J Cardiol $x MED00002299
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace